Nahdi Medical Company

SR 91.00As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:4164Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 5Y CAGR (7.18%)
Div yield 6.15%
ROE 30.65%
Medical (Pharmaceuticals)
Beta (5Y) 0.10
PE TTM 14.81
TSR TTM (17.04%)
Mkt cap SR 11.83B
ROIC 22.86%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 108
18.54%
(29.76%)
Hold 6|3|2|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
1.19
1.17
1.26
1.26
(5.52%)
(2.52%)
7.50%
10.28%
RevenueSR M
676.6
709.6
727.3
716.7
6.46%
10.62%
7.99%
3.01%
Peers (US$3.324B)
Cap (US$)
PE
874.1M
17.42x
Capital
TTM
5Y
10Y
Leveragex
1.086
0.166
0.159
EBIT/Intx
0.646
1.410
1.441
Own earn%
(16.52)
(14.74)
(15.07)
Sh yield%
18.05
11.13
11.54
Owners
Insiders/Inst%
2.06
67.52
Short interest%
1.07
SBC / revenue%
3.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
26–30
$1 testx
—
Incr. ROIC%
4